Association Between the A118G Polymorphism of the OPRM1 Gene and Suicidal Depression in a Large Cohort of Outpatients with Depression
Abstract : Background: Growing
evidences suggest that depression with suicidal ideation (SI) could be a
specific phenotype with its own characteristics. Moreover, opioid
system deregulation might be implicated in suicidal behaviour (SB). The
aim of this study was to determine whether the A118G polymorphism
(rs1799971) in ORPM1 (the gene encoding opioid receptor mu 1) is
associated with suicidal depression (ie, moderate to severe depression
with SI) in a large cohort of outpatients with depression.
Methods: GENESE is a large, prospective, naturalistic cohort of French
adult outpatients with depression (DSM-IV criteria), treated and
followed for 6 weeks. Depression severity was assessed with the Hospital
Anxiety and Depression Scale (HADS), and SI with the suicidal item of
the Montgomery-Åsberg Depression Rating Scale (MADRS-SI). From this
cohort, patients with moderate or severe depression (HADS-D subscale
score >11) were selected and classified as without SI (MADRS-SI <
2), or with SI (MADRS-SI ≥ 2).
Results: The AA/AG genotypes of the A118G polymorphism were
significantly associated with suicidal depression in the non-adjusted
(OR = 2.32, 95% CI = [1.28; 4.18]; p-value = 0.005) and in the adjusted
models (OR = 2.54, 95% CI = [1.35; 4.78]; p-value = 0.004).
Conclusion: Outpatients with depression harbouring the A allele are at
higher risk of SI (and possibly SB) than those carrying the G allele.
More studies are needed to better understand the link between this
polymorphism and SB.
Soumis le : jeudi 4 novembre 2021 - 11:49:02
Dernière modification le : vendredi 5 novembre 2021 - 04:23:03
Lien texte intégral https://www.dovepress.com/getfile.php?fileID=74926
Citation
Benedicte Nobile, Emilie Olie, Nicolas Ramoz, Jonathan Dubois, Sebastien Guillaume, et al.. Association Between the A118G Polymorphism of the OPRM1 Gene and Suicidal Depression in a Large Cohort of Outpatients with Depression. Neuropsychiatric Disease and Treatment, Dove Medical Press, 2021, 17, pp.3109-3118. ⟨10.2147/NDT.S324868⟩. ⟨hal-03414253⟩